RE:Like I said a couple days ago...This certainly heightens the prospect and value of a licensing deal with a major for IPF indication for North America and/or Europe. PLI has said they wont go this alone. This is the needed precursor.
Sooner than later we are going to wake up to the headline of an NA deal... and it will be a game changer instantly.... very little of that increasingly realistic prospect is priced in here